Connect
MJA
MJA

Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregivers

Melanie A Price, Phyllis N Butow, Daniel S J Costa, Madeleine T King, Lynley J Aldridge, Joanna E Fardell, Anna DeFazio and Penelope M Webb, , the Australian Ovarian Cancer Study Group and the Australian Ovarian Cancer Study Group Quality of Life Study Investigators
Med J Aust 2010; 193 (5 Suppl): S52.

Summary

Objectives: To assess the prevalence and predictors of depression and anxiety in women with ovarian cancer and their caregivers, to compare levels of depression and anxiety with community norms, and to explore the relationship between patients and their nominated caregivers.

Design, setting and participants: Prospective cohort study of 798 women with invasive ovarian cancer recruited between 1 January 2002 and 30 June 2006 through the nationwide Australian Ovarian Cancer Study, and 373 of their caregivers.

Main outcome measures: Depression and anxiety as assessed with the Hospital Anxiety and Depression Scale, and the role of demographic variables, disease and treatment variables, psychosocial variables, and use of mental health and support services as potential predictors.

Results: Rates of anxiety and depression among patients were significantly lower than in previous reports, although clinical depression rates (5.9%) were significantly higher than community norms (3.0%; χ2 = 24.0; P < 0.001). Caregivers also reported higher levels of depression (χ2 = 21.1; P < 0.001) and anxiety (χ2 = 17.6; P < 0.001) compared with norms. There was no difference within patient–caregiver pairs for depression (P = 0.1), while caregivers reported significantly higher anxiety than patients (P < 0.01). In patients, higher symptom burden, lower optimism and current specialist mental health treatment all significantly predicted both depression and anxiety, while lower social support was a significant predictor of patient anxiety only. In caregivers, lower social support and lower optimism were significant predictors of depression and anxiety. Patients being treated for mental health was also a predictor of their caregiver’s depression.

Conclusions: While depression is significantly more common in women with ovarian cancer than in the general population, it is caregivers of such patients who report much higher levels of both subclinical and clinical depression and anxiety.

  • Melanie A Price1,2
  • Phyllis N Butow1
  • Daniel S J Costa2
  • Madeleine T King2
  • Lynley J Aldridge2
  • Joanna E Fardell1
  • Anna DeFazio3,4
  • Penelope M Webb5
  • , the Australian Ovarian Cancer Study Group and the Australian Ovarian Cancer Study Group Quality of Life Study Investigators

  • 1 Centre for Medical Psychology and Evidence-based Decision-making, School of Psychology, University of Sydney, Sydney, NSW.
  • 2 Psycho-Oncology Co-operative Research Group, University of Sydney, Sydney, NSW.
  • 3 Department of Obstetrics and Gynaecology, University of Sydney, Sydney, NSW.
  • 4 Gynaecological Oncology Research Group, Westmead Institute for Cancer Research, Westmead Hospital, Sydney, NSW.
  • 5 Genetics and Population Health Division, Queensland Institute of Medical Research, Brisbane, QLD.


Acknowledgements: 

This study was funded by the Cancer Councils of New South Wales and Queensland (grant number RG 36/05 New South Wales). Financial support for the parent study was provided by the US Army Medical Research and Materiel Command (grant number DAMD17-01-1-0729), the National Health and Medical Research Council (NHMRC; grant numbers 400413, 400281) and the Cancer Councils of NSW, Queensland, South Australia, Tasmania, Victoria and Western Australia. Additional recruitment was conducted under the Australian Cancer Study (Ovarian Cancer), funded by the NHMRC (199600). Phyllis Butow is supported by an NHMRC Principal Research Fellowship (211199, 457093). Penelope Webb is supported by a Senior Research Fellowship from the NHMRC (496625). Full membership of the Australian Ovarian Cancer Study Group is listed at http://www.aocstudy.org/. We gratefully acknowledge the contribution of all our clinical and scientific collaborators and the cooperation of the following institutions: New South Wales — John Hunter Hospital, North Shore Private Hospital, Royal Hospital for Women, Royal North Shore Hospital, Royal Prince Alfred Hospital, Westmead Hospital, NSW Cancer Registry; Queensland — Mater Misericordiae Hospital, Royal Brisbane and Women’s Hospital, Townsville Hospital, Wesley Hospital, Queensland Cancer Registry; South Australia — Flinders Medical Centre, Queen Elizabeth Hospital, Royal Adelaide Hospital, Burnside War Memorial Hospital, South Australian Cancer Registry; Tasmania — Royal Hobart Hospital; Victoria — Freemasons Hospital, Mercy Hospital for Women, Royal Women’s Hospital, Victorian Cancer Registry; Western Australia — King Edward Memorial Hospital, St John of God Hospital (Subiaco), Sir Charles Gairdner Hospital, Western Australia Research Tissue Network (WARTN), Western Australian Cancer Registry. We also acknowledge the contribution of the study nurses and research assistants and would like to thank all of the women and caregivers who participated in the study.

Competing interests:

None identified.

  • 1. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries. Cancer in Australia 2000. Cancer series no. 23. Canberra: AIHW, 2003. (AIHW Cat. no. CAN 18.) http://www.aihw.gov.au/publications/index.cfm/title/9469 (accessed Jun 2010).
  • 2. National Breast Cancer Centre and National Cancer Control Initiative. Clinical practice guidelines for the psychosocial care of adults with cancer. Sydney: National Breast Cancer Centre, 2003.
  • 3. Holland JC, Andersen B, Breitbart WS, et al. Distress management: clinical practice guidelines in oncology. J Natl Compr Canc Netw 2007; 5: 66-98.
  • 4. Breen SJ, Baravelli CM, Schofield PE, et al. Is symptom burden a predictor of anxiety and depression in patients with cancer about to commence chemotherapy? Med J Aust 2009; 190 (7 Suppl): S99-S104. <MJA full text>
  • 5. Arden-Close E, Gidron Y, Moss-Morris R. Psychological distress and its correlates in ovarian cancer: a systematic review. Psychooncology 2008; 17: 1061-1072.
  • 6. Pitceathly C, Maguire P. The psychological impact of cancer on patients’ partners and other key relatives: a review. Eur J Cancer 2003; 39: 1517-1524.
  • 7. Edwards B, Clarke V. The psychological impact of a cancer diagnosis on families: the influence of family functioning and patients’ illness characteristics on depression and anxiety. Psychooncology 2004; 13: 562-576.
  • 8. Carlson LE, Bultz BD. Benefits of psychosocial oncology care: improved quality of life and medical cost offset. Health Qual Life Outcomes 2003; 1: 8.
  • 9. Matthews EE, Cook PF. Relationships among optimism, well-being, self-transcendence, coping, and social support in women during treatment for breast cancer. Psychooncology 2009; 18: 716-726.
  • 10. Brothers BM, Andersen BL. Hopelessness as a predictor of depressive symptoms for breast cancer patients coping with recurrence. Psychooncology 2009; 18: 267-275.
  • 11. Hoffman KE, McCarthy EP, Recklitis CJ, et al. Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Intern Med 2009; 169: 1274-1281.
  • 12. Steginga SK, Campbell A, Ferguson M, et al. Socio-demographic, psychosocial and attitudinal predictors of help seeking after cancer diagnosis. Psychooncology 2008; 17: 997-1005.
  • 13. Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 national health interview survey. J Natl Cancer Inst 1999; 91: 1480-1486.
  • 14. Owen JE, Goldstein MS, Lee JH, et al. Use of health-related and cancer-specific support groups among adult cancer survivors. Cancer 2007; 109: 2580-2589.
  • 15. Pascoe S, Edelman S, Kidman A. Prevalence of psychological distress and use of support services by cancer patients at Sydney hospitals. Aust N Z J Psychiatry 2000; 34: 785-791.
  • 16. Glasdam S, Jensen AB, Madsen EL, et al. Anxiety and depression in cancer patients’ spouses. Psychooncology 1996; 5: 23-29.
  • 17. Begbie S, Underhill C. Cancer services to be proud of in rural Australia: lessons learnt from the Clinical Oncological Society of Australia Cancer Service audit. Cancer Forum 2007; 31: 90-93.
  • 18. Jordan SJ, Green AC, Whiteman DC, et al. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis. Int J Cancer 2008; 122: 1598-1603.
  • 19. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-370.
  • 20. Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA, et al. Reliability and validity of the functional assessment of cancer therapy — ovarian. J Clin Oncol 2001; 19: 1809-1817.
  • 21. Broadhead WE, Gehbach SH, de Gruy FV, et al. The Duke-UNC Functional Social Support Questionnaire. Med Care 1988; 26: 709-723.
  • 22. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self mastery, and self esteem): a reevaluation of the life orientation test. J Pers Soc Psychol 1994; 67: 1063-1078.
  • 23. Crawford JR, Henry JD, Crombie C, et al. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 2001; 40: 429–434.
  • 24. Zabora J, BrintzenhofeSzoc K, Curbow B, et al. The prevalence of psychological distress by cancer site. Psychooncology 2001; 10: 19-28.
  • 25. Mirabeau-Beale KL, Kornblith AB, Penson RT, et al. Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol 2009; 114: 353-359.
  • 26. Bettencourt BA, Schlegel RJ, Talley AE, et al. The breast cancer experience of rural women: a literature review. Psychooncology 2007; 16: 875-887.
  • 27. Clinical Oncological Society of Australia. Publications. Mapping rural and regional oncology services in Australia. March 2006. http://www.cosa.org.au//PublicationsPositionStatements/Publications.htm (accessed April 2010).

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.